{"entity":{"type":"insider","cik":"0001571997","url":"/insider/0001571997","json_url":"/insider/0001571997.json","name":"Gullans Steven R. Ph.D.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2013-03-27","last":"2018-02-12","span_basis":"filed_date"},"name_variants":[{"name":"Gullans Steven R. Ph.D.","source":"filing","n_filings":6,"first_seen":"2013-03-27","last_seen":"2018-02-12"}],"transactions":[{"id":6843705,"accession":"0001596771-18-000019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001596771-18-000019","line_url":"/filing/0001596771-18-000019#line-1","is_derivative":false,"issuer_cik":"0001571997","issuer_name":"Gemphire Therapeutics Inc.","issuer_ticker":"GEMP","issuer_name_source":null,"issuer_url":"/issuer/0001571997","owner_cik":"0001571997","owner_name":"Gullans Steven R. Ph.D.","owner_url":"/insider/0001571997","role":"Director, Officer (Interim President & CEO)","officer_title":"Interim President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":71429.0,"shares_display":"71,429","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":500003.0,"total_display":"500,003.00","shares_owned_after":930252.0,"shares_owned_after_display":"930,252","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-08","filed_date":"2018-02-12","scope":"insider"},{"id":5009866,"accession":"0000899243-17-018010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-17-018010","line_url":"/filing/0000899243-17-018010#line-2","is_derivative":false,"issuer_cik":"0001420565","issuer_name":"AILERON THERAPEUTICS INC","issuer_ticker":"ALRN","issuer_name_source":null,"issuer_url":"/issuer/0001420565","owner_cik":null,"owner_name":"Excel Medical Ventures, LLC; Gullans Steven R. Ph.D.; Blume Frederick R.; Enriquez Juan; EXCEL MEDICAL FUND LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":900000.0,"total_display":"900,000.00","shares_owned_after":1016100.0,"shares_owned_after_display":"1,016,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-05","filed_date":"2017-07-06","scope":"insider"},{"id":4713259,"accession":"0001596771-17-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001596771-17-000020","line_url":"/filing/0001596771-17-000020#line-1","is_derivative":false,"issuer_cik":"0001571997","issuer_name":"Gemphire Therapeutics Inc.","issuer_ticker":"GEMP","issuer_name_source":null,"issuer_url":"/issuer/0001571997","owner_cik":"0001571997","owner_name":"Gullans Steven R. Ph.D.","owner_url":"/insider/0001571997","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":52798.0,"shares_display":"52,798","price_per_share":9.47,"price_display":"9.47","price_state":"stated","total_value":499997.06,"total_display":"499,997.06","shares_owned_after":858823.0,"shares_owned_after_display":"858,823","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-10","filed_date":"2017-03-14","scope":"insider"},{"id":3036794,"accession":"0001104659-16-139272","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-16-139272","line_url":"/filing/0001104659-16-139272#line-2","is_derivative":false,"issuer_cik":"0001571997","issuer_name":"Gemphire Therapeutics Inc.","issuer_ticker":"GEMP","issuer_name_source":null,"issuer_url":"/issuer/0001571997","owner_cik":"0001571997","owner_name":"Gullans Steven R. Ph.D.","owner_url":"/insider/0001571997","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","shares_owned_after":806025.0,"shares_owned_after_display":"806,025","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-10","filed_date":"2016-08-12","scope":"insider"},{"id":7000438,"accession":"0001209191-14-035920","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-035920","line_url":"/filing/0001209191-14-035920#line-1","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001571997","owner_name":"Gullans Steven R. Ph.D.","owner_url":"/insider/0001571997","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":9.2391,"price_display":"9.24","price_state":"stated","total_value":230977.5,"total_display":"230,977.50","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-19","filed_date":"2014-05-21","scope":"insider"},{"id":4772581,"accession":"0001181431-13-019217","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-019217","line_url":"/filing/0001181431-13-019217#line-2","is_derivative":false,"issuer_cik":"0001373707","issuer_name":"TETRAPHASE PHARMACEUTICALS INC","issuer_ticker":"TTPH","issuer_name_source":null,"issuer_url":"/issuer/0001373707","owner_cik":"0001571997","owner_name":"Gullans Steven R. Ph.D.","owner_url":"/insider/0001571997","role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":496121.0,"shares_display":"496,121","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":3472847.0,"total_display":"3,472,847.00","shares_owned_after":1468505.0,"shares_owned_after_display":"1,468,505","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-03-25","filed_date":"2013-03-27","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001638287","name":"Gemphire Therapeutics Inc.","url":"/issuer/0001638287","role":"Director, Officer (Interim President & CEO)","n_filings":3,"first_seen":"2016-08-12","last_seen":"2018-02-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001420565","name":"AILERON THERAPEUTICS INC","url":"/issuer/0001420565","role":"Ten percent owner","n_filings":1,"first_seen":"2017-07-06","last_seen":"2017-07-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001373707","name":"TETRAPHASE PHARMACEUTICALS INC","url":"/issuer/0001373707","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2013-03-27","last_seen":"2014-05-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001571997","retrieved_at":"2026-08-21T17:36:11+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}